This article was originally published in The Tan Sheet
Warner-Wellcome will market new OTC formulations using Penederm's TopiCare delivery system in the U.S. and Canada under a license agreement announced by Penederm. The topical products are expected to be launched in the summer. Terms of the deal will include supply arrangements, fees and royalties payable to Penederm, the company said
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC